Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

After all rebates and discounts are tallied, the typical patient today pays $5 per vial of Humalog, a popular insulin, and just $3.40 for its unbranded equivalent. Patients typically need about ...

In reality, patients pay much lower net prices. After all rebates and discounts are tallied, the typical patient today pays $5 per vial of Humalog, a popular insulin, and just $3.40 for its unbranded ...

In the kitchen of her South St. Paul home, Abigail Turner prepares the insulin she uses to manage her type 1 diabetes last February. Minnesota announced a final settlement Monday with the last of ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe Biden on lowering prescription drug costs in posts online that suggest ...

The message warning about insulin manufacturers announcing 2,000%-3,000% price increases after President Donald Trump rescinded a Joe Biden executive order originated as satire. This article was ...